Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 May 15;25(10):2943-2945.
doi: 10.1158/1078-0432.CCR-19-0188. Epub 2019 Mar 5.

Tumor Landscapes: β-Catenin Drives Immune Desertification

Affiliations
Free article
Comment

Tumor Landscapes: β-Catenin Drives Immune Desertification

Denarda Dangaj et al. Clin Cancer Res. .
Free article

Abstract

Immune checkpoint blockade therapy requires a preestablished activated immune landscape. Understanding tumor-intrinsic mechanisms that lead to T-cell desertification is key to resensitizing them to such therapies. The WNT/β-catenin tumor-intrinsic signaling is emerging as an immune exclusion pathway that holds high promise to counteract resistance to immunotherapy.See related article by Luke et al., p. 3074.

Comment on

Similar articles

See all similar articles

Cited by 1 article

LinkOut - more resources

Feedback